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We evaluated the sensitivity and dose dependency of radiation-induced injury in hematopoietic stem/
progenitor cells. Adult C57BL/6 mice were daily exposed to 0, 2, 10, 50, and 250 mGy c-ray for 1 month in
succession, respectively. The damage of hematopoietic stem/progenitor cells in bone marrow were
investigated within 2 hours (acute phase) or at 3 months (chronic phase) after the last exposure. Daily
exposure to over 10 mGy c-ray significantly decreased the number and colony-forming capacity of
hematopoietic stem/progenitor cells at acute phase, and did not completely recover at chronic phase with
250 mGy exposure. Interestingly, the daily exposure to 10 or 50 mGy c-ray decreased the formation of
mixed types of colonies at chronic phase, but the total number of colonies was comparable to control.
Immunostaining analysis showed that the formation of 53BP1 foci in c-kit1 stem/progenitor cells was
significantly increased with daily exposure to 50 and 250 mGy at acute phase, and 250 mGy at chronic
phase. Many genes involved in toxicity responses were up- or down-regulated with the exposures to all doses.
Our data have clearly shown the sensitivity and dose dependency of radiation-induced injury in
hematopoietic stem/progenitor cells of mice with daily exposures to 2 , 250 mGy c-ray.
T
he exposure to high levels of ionizing radiation is well known to lead to DNA double-strand breaks, which
elicit cell death or stochastic change1. As we are always enveloped in a constant exposure to natural ionizing
radiation, the detrimental health effects of exposure to low-dose ionizing radiation is still questionable2. By
now, the risk evaluation of radiation was general obtained from the epidemiological studies of radiation-exposed
human populations because of the lack of ideal in vivo and in vitro approaches for examination. The Life Span
Study (LSS) cohort of atomic bomb survivors demonstrated a statistically significant increase in cancer at doses
above 100 mGy, but failed to show a significance of cancer risk at lower doses of exposure3. However, a recently
cohort study have found that the medical exposure in children to deliver cumulative doses of about 50 mGy might
almost triple the risk of leukemia and doses of about 60 mGy might triple the risk of brain cancer4. With the
accident of Fukushima Nuclear Power Station in Japan, scientific data is highly and urgently wanted to answer
whether a low-dose radiation exposure also induces healthy problem, especially in the future of life span.
Significant advancement of recent studies on stem cells has clearly demonstrated that the small population of
tissue-specific stem cells plays critical role in repairing/regenerating the organs due to physiological turnover or
non-physiological damage5–7. Increasing evidences have also shown that the carcinogenesis, one of the major
problems at late phase after radiation is mainly originated from the tissue stem cells, rather than the matured
somatic cells8,9. Considering that the changes of stem cells in quality and quantity may serve as potential reliable
indicators for sensitively predicting the future health problems in both of cancer and non-cancer risks, many
radiobiologists have recently intended to use stem cells as a tool for evaluating radiation-induced injury, especially
at the late phase10–12.
Generally, low dose is defined as a dose between background radiation (0.01 mSv/day) and high-dose radiation
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and then investigated the sensitivity and dose dependency of radi-
ation-induced injury in hematopoietic stem/progenitor cells at the
acute and chronic phases after a series of radiation exposures.
Results
Daily exposure to 250 mGy c-ray for 1 month significantly decreased
bone marrow mononuclear cells (BM-MNCs). All mice survived from
the daily radiation exposures to 2 , 250 mGy c-ray for 1 month in
succession, as well as within 3 months of follow-up. The body weight
was not significantly differed among groups at both of the acute and
chronic phases after radiation exposures (Supplementary Figure 1).
Although the well-trained skill with a defined protocol, signifi-
cantly less numbers of BM-MNCs were collected from mice soon
after the completion of daily exposures to 250 mGy for 1 month (p ,
0.05 vs. Control, Fig 1A). No significantly difference in the total
number of BM-MNCs was found to be decreased by the exposures
to 50 mGy or less (Fig 1A). The decreased number of BM-MNCs
with daily 250 mGy radiation exposures was completely recovered
within 3 months of follow-up (Fig 1B).
Daily exposure to c-ray over 10 mGy for 1 month significantly
damaged hematopoietic stem/progenitor cells. We quantified the
hematopoietic stem/progenitor cells in BM-MNCs by flow
cytometry. Compared with the healthy mice, the percentage of
CD341 stem/progenitor cells in the isolated BM-MNCs was
significantly decreased in the mice daily exposed to over 50 mGy
c-ray for 1 month (Fig 2A). However, the percentage of c-kit1
stem/progenitor cells in BM-MNCs was significantly decreased in
the mice daily exposed to over 10 mGy c-ray for 1 month (Fig 2C).
Both the percentage of CD341 and c-kit1 stem/progenitor cells at
chronic phase was still significantly impaired even 3 months after the
completion of daily exposures to 250 mGy for 1 month (Fig 2B, 2D).
By using colony forming assay, we found that the total number of
colonies grew from BM-MNCs was significantly decreased in the
mice daily exposed to over 50 mGy c-ray at acute phase (p , 0.01
vs. Control, Fig 3A), and also significantly decreased in the mice daily
exposed to 250 mGy c-ray at chronic phase (p , 0.01 vs. Control,
Fig 3B). To further distinct the sensitivity of different types of stem/
progenitor to radiation injury, we also counted the mixed colonies
that grown from an early stage stem/progenitor cell with multiple
differentiation potency. Interestingly, even if with a daily exposure to
10 mGy for 1 month, the formation of mixed colonies was signifi-
cantly decreased (p , 0.01 vs. Control, Fig 3C), and this decrease did
not completely recovered in 3 months after the completion of daily
radiation exposures (p , 0.01 vs. Control, Fig 3D).
Neither ROS level nor 53BP1 expression sensitively indicated the
radiation-induced damage of hematopoietic stem/progenitor
cells. To understand the mechanism on radiation induced damage,
we purified c-kit1 stem/progenitor cells for experiments by magnetic
cell sorting, and the purity was over 90% by flow cytometry analysis.
Unexpectedly, the levels of intracellular ROS in c-kit1 cells was only
increased after daily exposure to 50 mGy at the acute phase (p , 0.01
vs. Control, Fig 4A), and was not significantly different among
groups at chronic phase (Fig 4B). Given that mitochondria
contribute to the increased levels of ROS function to perpetuate
the oxidative stress, we also measured the mitochondrial ROS in c-
kit1 cells. We found that the mitochondrial ROS levels was increased
with daily exposure to 250 mGy c-ray at the acute phase (p , 0.01 vs.
Control, Fig 4C), and also increased even 3 months after the
completion of daily exposures to over 50 mGy c-ray (p , 0.01 vs.
Control, Fig 4D).
We further evaluated the DNA damage in the purified c-kit1 stem
cells based on counting the purified c-kit1 stem cells with the forma-
tion of 53BP1 foci in nucleus. A quantitative analysis showed that the
percentages of cells with 53BP1 foci were significantly increased in
the purified c-kit1 stem cells from mice daily suffered to 50 and
250 mGy for 1 month at the acute phase (p , 0.05 vs. Control,
Fig 5A), and also increased in cells from mice daily suffered to
250 mGy at the chronic phase (p , 0.05 vs. Control, Fig 5B).
Radiation-induced changes on the expressions of genes involved in
toxicity response in hematopoietic stem/progenitor cells. Among
the 370 genes included in the Mouse Molecular Toxicology Pathway
Finder RT2 Profiler PCR array (Supplementary Table 1), a total of 23,
17, 15, and 37 genes involved in toxicity response were detected to be
up- or down-regulated over 3-fold in these c-kit1 stem cells at the
acute phase by the daily exposures to 2, 10, 50, and 250 mGy for 1
month, respectively (Fig 6A). There was still detected 16, 14, 19, and
24 genes that up- or down-regulated over 3-fold in c-kit1 stem cells
even 3 months after the completion of daily exposures to 2, 10, 50,
and 250 mGy, respectively (Fig 6B).
The top 20 genes of up- or down-regulation with different doses of
exposures were listed up in table (Table). Some genes, such as the
Csf2, were found to be up-regulated with all doses of exposures.
However, we noticed that each dose of radiation exposure also spe-
cifically induced the up- and down-regulation in some genes. These
genes specifically changed in each dose of radiation were indicated as
red bond fonts in the table (Table). Of that, daily exposure to 2 mGy
specifically up-regulated Nr0b2 and HSPb8, 10 mGy specifically up-
regulated Lig4 and Prkdc, and 50 mGy specifically down-regulated
Trim10 and Tnfsf10 at the acute phase. Otherwise, daily exposure to
Figure 1 | The number of mononuclear cells collected from the bone marrow of mice after radiation exposures. The bone marrow was collected from
the femur and tibia soon (A) or 3 months (B) after daily radiation exposures to 2, 10, 50, and 250 mGy c-ray, and the number of total collected
mononuclear cells from each mouse was directly counted. * p,0.05 vs control.
www.nature.com/scientificreports
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250 mGy c-ray specifically up-regulated Hsph1 and Abl1 at the
chronic phase.
Discussion
By daily exposure of health mice to 2 , 250 mGy c-ray for 1 month,
we herein demonstrated that radiation exposures declined the num-
ber and colony formation capacity of hematopoietic stem/progenitor
cells in bone marrow, in a dose dependent manner. Our data has also
suggested that these hematopoietic stem/progenitor cells at earlier
stage seem to be more sensitive to radiation, although we did not
directly compare with these late stage progenitor cells with limited
differentiation potency. Furthermore, the dose-dependent response
of hematopoietic stem/progenitor cells to radiation exposures was
also characterized in that different dose of radiation exposure spe-
cifically induced the expression change in some genes associated with
toxicity response.
DNA damage is known as the direct consequence of high dose
ionizing radiation. Moderate or high dose of whole body radiation
exposure are well known to cause long-term hematopoietic damage,
which has already been experimentally evidenced by the quantitative
and/or qualitative defects of hematopoietic stem/progenitor
cells14–17. We confirmed that daily exposures to over 50 mGy c-ray
for 1 month significantly induced the formation of 53BP1 foci, one of
the markers popularly used for DNA damage identification18, in c-
kit1 stem/progenitor cells of mice after radiation exposure.
Differed from high dose radiation exposure can directly induce
DNA double-strand breaks, the exposure to relatively low dose of
radiation is generally thought to induce DNA damage indirectly
through the trigger of ROS release, which may finally leading to
delayed radiobiological effect19. Recently, it is widely implicated that
ROS might play a critical role in intracellular signal induction and
gene expression that involves in regulation of hematopoietic stem cell
biology and lineage commitment20. The imbalance of ROS home-
ostasis might induce a series of biological changes and finally resulted
in significant damage to the hematopoietic stem/progenitor cells21.
In the present study, a modest increase of intracellular ROS levels in
c-kit1 stem/progenitor cells was only found with daily 50 mGy expo-
sures at the acute phase, and no difference at the chronic phase. In
contrast, the mitochondrial ROS levels increased with daily 250 mGy
exposures at acute phase, as well as with the daily 50 and 250 mGy
exposures at chronic phase. However, neither the intracellular ROS
levels nor the mitochondrial ROS levels precisely indicated the radi-
ation-induced injures in the number and function of c-kit1 stem/
progenitor cells. Therefore, further investigation is needed to con-
firm the role of ROS in radiation-induced injury in hematopoietic
stem/progenitor cells.
Of interesting, daily exposure to 10 mGy c-ray for 1 month sig-
nificantly decreased the number of mixed type of colonies that
formed from the early stage hematopoietic stem/progenitor cells,
but not the total number of colonies at both of the acute and chronic
phases. Otherwise, daily exposed to 10 mGy c-ray for 1 month also
significantly decreased the percentage of c-kit1 cells, but not CD341
cells in BM-MNCs at acute phase. As these early stage hematopoietic
stem/progenitor cells with multiple differentiation potency are
Figure 2 | The number of hematopoietic stem/progenitor cells in the bone marrow of mice after radiation exposures. The mononuclear cells was
isolated from bone marrow of mice by gradient centrifugation, soon (A,C) or 3 months (B,D) after daily radiation exposures to 2, 10, 50, and 250 mGy c-
ray. The c-kit-positive cells (A,B) or CD34-positive cells (C,D) within bone marrow mononuclear cells were measured by flow cytometry. * p,0.05 vs
control; ** p,0.01 vs control.
www.nature.com/scientificreports
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known to be weakly/negatively expressed with CD34, we speculated
that these hematopoietic stem/progenitor cells at earlier stage
showed higher sensitivity to radiation-induced injury when com-
pared to these late stage hematopoietic progenitor cells that with
limited lineage differentiation potency. In fact, it has also previously
reported that varying doses of radiation treatment can alter the dif-
ferentiation of stem cells into their adult progenitor cells22,23.
Although some of parameters indicated a recovery of radiation-
induced damage in c-kit1 stem/progenitor cells within 3 months
after the completion of radiation exposures, the formation of mixed
colonies still showed significantly impaired with daily exposures to
over 10 mGy c-ray for 1 month. Longer term follow-up may help to
answer whether the radiation-induced injury to these hematopoietic
stem/progenitor cells at early stage will be permanent or recoverable.
By extensive screening the changes of gene expression, we found
that a number of genes involved in toxicity responses were up- or
down-regulated over 3-fold in c-kit1 stem/progenitor cells at acute
phase, even by the daily exposure to a dosage of 2 mGy
(Supplementary Table 1). Some gene, such as Csf2, was generally
enhanced in response to all doses of radiation exposures in study,
and the number of genes with over 3-fold change was not propor-
tionally increased with the doses of radiation exposure. The most
interesting finding to us was the dose specificity on the gene express-
ion changes. Our data showed that the daily exposure to 2 mGy, but
not other doses, largely up-regulated HspB8 and Nr0b2. The HspB8, a
small heat shock protein, has been demonstrated to implicate in
autophagy and participate in protein quality control by a non-cha-
perone-like mechanism24. The Nr0b2, an orphan nuclear receptor
small heterodimer partner, has been reported to be a potential tumor
suppressor in human liver cancer25. Therefore, we speculate that the
specifically up-regulation of HspB8 and Nr0b2 in response to 2 mGy
of low dose radiation may beneficial of the protein quality control in
the stem cells and inhibit carcinogenesis. However, it is still kept to
discreetly claim the concept that a subtle dose radiation exposure will
benefit the cells instead of inducing defect to the cells26,27.
Daily exposure to10 mGy showed to specifically up-regulate
Prkdc and Lig4, two genes that well known to relevant with DNA-
damage repair28. Although the expression of 53BP1 in c-kit1 stem/
progenitor cells was not changed with 10 mGy exposures by
immunostaining analysis, the up-regulation of Prkdc and Lig4 may
due to some radiation-induced repairable DNA damages in these c-
kit1 stem/progenitor cells with daily 10 mGy exposures.
Down-regulation of Trim10 and Tnfsf10 was specially observed in
the c-kit1 stem/progenitor cells with daily exposure to 50 mGy. The
Trim10 has been demonstrated to be a key factor required for ter-
minal erythroid cell differentiation and survival29. The Tnfsf10 is
known as a p53-transcriptional target gene30. The largely down-regu-
lation of Trim10 and Tnfsf10 in the c-kit1 stem/progenitor cells with
daily exposure to 50 mGy probably indicates a severe damage of
hematopoiesis and the increased risk of carcinogenesis.
Similar to the acute phase, many genes was still detected to be up-
and down-regulated over 3-fold in these in c-kit1 stem/progenitor
cells at the chronic phase. The expression of some genes, including
the Abl1 and Hsph1 was specifically up-regulated even 3 months after
the completion of daily exposure with a very high dose of 250 mGy.
The mutation in the Abl1 gene has previously been demonstrated to
associate with chronic myelogenous leukemia31. On the other hand,
Hsph1 has been displayed a direct correlation between HSP105
expression and lymphoma aggressiveness32. As the carcinogenesis
are considering to be originated from the stem cells rather than
Figure 3 | Colony-forming assay. Bone marrow mononuclear cells were isolated from mice soon (A,C) or 3 months (B,D) after daily radiation exposures
to 2, 10, 50, and 250 mGy c-ray, and then cultured in methylcellulose complete medium. The colony formation was observed under microscopy at
9 days after incubation. The number of all types of colonies (.30 cells) and the mixed colonies (at least two types of cells in colony) were counted, and data
was represent the mean of duplicate assays. * p,0.05 vs control; ** p,0.01 vs control.
www.nature.com/scientificreports
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matured tissue cells, the increased expressions of Abl1 and Hsph1 in
these c-kit1 hematopoietic stem/progenitor cells may finally contrib-
ute to increase the risk of carcinogenesis and to enhance the aggres-
siveness of cancer.
Although the extensive changes of gene expression were detected,
further experiment is highly required for uncovering the mechanism
and significance of these changes of gene expression with both cell
biological and radiobiological views. Otherwise, we did only purify
the c-kit1 stem/progenitor cells using for study, it is still kept unclear
about the sensitivity and dose-dependency of radiation-induced
injury to these lin2 sca-11 c-kit1 (LSK) long-term hematopoietic
stem cells.
In summary, data from the present study has clearly indicated the
sensitivity and dose dependency of radiation-induced injury of
hematopoietic stem/progenitor cells in bone marrow of mice after
daily exposures to c-ray with a wide dose range from 2 to 250 mGy,
further experiment is badly in need in ascertaining the exact effect of
low dose radiation exposure, especially the lowest dose level of radi-
ation exposure for evidence of elevated cancer and non-cancer risks.
Methods
Animals. We used 12-week-old male C57BL/6 mice (SLC, Japan) for the present
study. All experiments were approved by the Institutional Animal Care and Use
Figure 4 | Intracellular and mitochondrial ROS in the hematopoietic stem/progenitor cells. The c-kit-positive stem/progenitor cells were purified from
freshly collected bone marrow mononuclear cells isolated from mice soon (A,C) or 3 months (B,D) after daily radiation exposures to 2, 10, 50, and
250 mGy c-ray. After 12 hours incubation, cells were then loaded with 10 mM CM-H2DCFDA or 5 mM MitoSOX Red at 37uC for 30 minutes. The
intracellular ROS (A,B) and mitochondrial ROS (C,D) were detected as the mean fluorescence intensity in all cells by flow cytometry. * p,0.05 vs control;
** p,0.01 vs control.
Figure 5 | DNA damage in the c-kit1 hematopoietic stem/progenitor cells. The c-kit-positive stem/progenitor cells were purified from freshly collected
bone marrow mononuclear cells isolated from mice soon (A) or 3 months (B) after daily radiation exposures to 2, 10, 50, and 250 mGy c-ray. After 24 hours
incubation, cells were fixed and the DNA damage in the cells was estimated by immunostaining with an anti-53BP1 antibody. * p,0.05 vs control.
www.nature.com/scientificreports
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Committee of Nagasaki University (No. 1108120943), and experiments were
performed in accordance with the institutional and national guidelines.
Radiation exposures. Whole-body radiation was performed by exposing the mice to
0, 2, 10, 50, and 250 mGy c-ray daily for 30 days in succession (with accumulative
doses of 0, 60, 300, 1500, and 7500 mGy), respectively33. The mice were sacrificed
within 2 hours (acute phase) or 3 months later (chronic phase) after the last exposure,
and bone marrow cells were collected and used for the following experiments.
Measurement of the number of mononuclear cells and stem cells in bone marrow.
Bone marrow cells were collected from the femur and tibia. The bone marrow
Figure 6 | Expression of genes involved in toxicity responses in the hematopoietic stem/progenitor cells. PCR array was performed to compare the
expression of 370 genes involved in toxicity responses. The number of genes that up- or down-regulated over 3-fold in freshly purified c-kit-positive
stem/progenitor cells from mice soon (A) or 3 months (B) after daily radiation exposures to 2, 10, 50, and 250 mGy c-ray.
Table | The top 20 genes that up- or down-regulated in c-kit-positive stem/progenitor cells soon (acute phase) or 3 months (chronic phase)
after the completion of daily exposures to 2, 10, 50, and 250 mGy c-ray for 1 month
2 mGy 10 mGy 50 mGy 250 mGy
Gene symbol Fold change Gene symbol Fold change Gene symbol Fold change Gene symbol Fold change
Acute phase Slc10a1 10.3566 Slc10a1 9.2412 Slc10a1 6.1527 Csf2 20.5222
Csf2 6.8328 Lig4 8.1008 Txnl4b 4.6629 Ubqln2 19.961
Nr0b2 5.8664 Sc4mol 6.225 Mbtps2 4.1446 Retn 19.6862
Acot3 5.6666 Prkdc 4.5887 Sc4mol 3.9757 Cyp1a2 8.1067
Hspb8 5.3982 Hspa1a 4.2518 Csf2 3.9483 Atp6v1g2 7.0573
Mag 5.3982 Lss 4.107 Ptgs2 3.5094 Cd19 6.4492
Aco1 4.5709 Acot3 3.8586 Serpina3k 3.4851 Acot3 6.3604
Serpina3k 4.3847 Haao 3.7792 Sycp2 3.4851 Lpl 6.0591
Ehhadh 4.3244 Serpina3k 3.4776 Aco1 3.2971 Jph3 5.9344
Atp6v1g2 4.0069 Ephx1 3.4297 Cd19 2.8703 Slc10a1 5.8527
Eno1 22.0244 Ly6d 22.2688 Hspa1l 22.4096 Fbxo6 22.6775
Ctsb 22.1251 Htra2 22.3005 Jag1 22.4773 Mrps18b 22.6775
Aldh2 22.1547 Tagln 22.4485 Cdkn1a 22.5647 Cpt2 22.7912
Dhcr24 22.3416 Gpx4 22.4485 Scd1 22.9257 Fxc1 23.2063
Cd86 22.6713 Gpx3 22.5525 Gpx3 23.5278 Bcl2l11 23.3657
Acox1 23.3346 Trim10 22.5703 Cpt1b 23.9416 Tnfsf10 23.5086
Icam1 23.4522 Idh1 22.8322 Icam1 24.109 Bcl2 23.533
Cd36 23.5739 Mrps18b 23.3448 Acadsb 24.5277 Atf4 23.5823
Ep300 24.077 Acox1 23.7371 Trim10 24.6874 Dld 24.6942
Gpx3 24.1627 Tnfsf10 24.4442 Tnfsf10 29.9782 Acat2 29.5857
Chronic phase Csf2 8 Cyld 7.4643 Eif2ak3 5.6962 Cyld 15.0324
Cyld 5.5022 Bax 6.9644 Bmf 5.0281 Hsph1 6.498
Srebf1 5.2054 Bmf 4 Cyld 4.8568 Abl1 6.0629
Bax 4.2871 Fmo4 4 Bax 4.0558 Bmf 5.7358
Mrps18b 3.9177 Eif2ak3 3.8371 Csf2 3.7064 Bax 5.3517
Bcl2l1 3.605 Csf2 3.2944 Acaa2 3.5064 Csf2 4.7568
Ugt2b1 3.4822 Srebf1 3.249 Nudt13 3.2944 Fas 4.4691
Hadhb 3.3636 Sdhc 3.249 Commd4 3.2716 Mag 4.1989
Amfr 3.1821 Cyp1a2 3.1821 Pcca 3.0525 Ahsg 4.0278
Acaa1a 2.8481 Cyld 3.0951 Fmo4 3.0314 Ubqln2 4.0278
Idh1 22.7511 Gpx1 22.6574 Dnajb1 22.9282 Pcna 22.3295
Fh1 22.9282 Sod1 22.7321 Ptprc 22.969 Ubxn4 22.3457
Tnfrsf1a 22.9897 Ero1l 22.7702 Atf4 23.0951 Xbp1 22.5847
Os9 23.2266 Brca1 22.8879 Brca1 23.1821 Acat1 22.6208
Sdha 23.2944 Acadl 22.9282 Cflar 23.3636 Fbxo6 22.6208
Serp1 23.4343 Xbp1 22.969 Fxc1 23.5308 Ppp1r15b 23.1167
Bcl2 23.4581 Eif5b 23.0738 Rad51 24.0278 Sod1 23.1383
Idh3a 23.8106 Cflar 23.4343 Xbp1 24.2281 Ero1l 23.1821
Dlat 24.1699 Serp1 23.7842 Casp8 24.4076 Serp1 23.249
Acly 26.021 H47 26.5432 H47 26.3203 Gadd45a 23.6301
www.nature.com/scientificreports
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mononuclear cells (BM-MNCs) were isolated by density gradient centrifugation33,34,
and then counted using a Nucleo Counter cell-counting device (Chemotetec A/S,
Denmark). To measure the c-kit-positive (c-kit1) and CD34-positive (CD341) stem/
progenitor cells in the isolated BM-MNCs, we labeled cells with a PE-conjugated anti-
mouse c-kit antibody (eBioscience) or a FITC-conjugated anti-mouse CD34 antibody
(BD Bioscience) for 30 minutes. Respective isotype controls were used as a negative
control. After washing, quantitative flow cytometry analysis was performed using a
FACSCalibur (Becton Dickinson)33,34. We analyzed the acquired data using Cell
Quest software (Becton Dickinson).
Colony-forming assay. The colony-forming capacity of the isolated cells was
evaluated using mouse methylcellulose complete medium33,34, according to the
manufacturer’s instructions (R&D System). Briefly, 3 3 104 BM-MNCs were mixed
well with 1 ml of medium, plated in 3-cm culture dishes, and then incubated at 37uC
in a 5% CO2 incubator. The formation of colonies was observed under a microscope,
and the total number of colonies in each dish was counted after 9 days of incubation.
We also counted the number of mixed colonies, in which at least two types of cells was
grown from a single stem/progenitor cell. The mean number of colonies in duplicate
assays was used for the statistical analysis.
Purification of c-kit1 stem/progenitor cells. The c-kit1 stem/progenitor cells were
purified by sorting, using the Magnetic Cell Sorting system (autoMACS, Miltenyi
Biotec, Auburn, CA)35. Briefly, freshly collected BM-MNCs were incubated with anti-
mouse CD117 (c-kit) antibody (Miltenyi Biotec) for 30 minutes. After washing, c-kit1
cells were separated by passing a MACS column. The purity of the c-kit1 cells
collected by the autoMACS was about 90%, and the viability was more than 99%.
Detection of intracellular and mitochondrial ROS levels in c-kit1 stem/progenitor
cells. To measure the intracellular and mitochondrial ROS levels, freshly purified c-
kit1 cells were seeded on 96-well culture plate at a density of 1 3 104 cells/well in
100 ml IMDM 1640 medium supplemented with 10% fetal bovine serum (HyClone)
and incubated at 37uC in 5% CO2 for 12 hours. Cells were then incubated with 10 mM
CM-H2DCFDA or 5 mM MitoSOX Red (Molecular Probes Inc.)36,37, at 37uC for 30
minutes. After washing, the fluorescence intensity in the c-kit1 cells was measured by
plate reader (VICTORTM 33 Multilabel Plate Reader, PerkinElmer Inc., Waltham,
Massachusetts, USA).
Immunocytochemistry. To detect the DNA damage, freshly purified c-kit1 cells were
seeded on 4-well chamber culture slides (Nalge Nunc International, Roskilde,
Denmark) coated with 10 mg/ml fibronectin (Invitrogen) at a density of 3 3 104 cells/
ml in IMDM 1640 medium supplemented with 10% fetal bovine serum (HyClone).
Cells were incubated at 37uC in 5% CO2 for 24 hours, and then fixed in 1%
formaldehyde for 10 min. After blocking with 2% bovine serum albumin, the cells
were reacted with anti-mouse 53BP1 antibody (Abcam), followed by a FITC-
conjugated secondary antibody. The nuclei were stained with Hoechst 33258. The
positively stained cells were observed under fluorescence microscopy with 200-fold
magnification, and more than 200 cells were counted to calculate the percentage of
cells with 53BP1 foci in the nucleus33,34.
Mouse Molecular Toxicology Pathway Finder RT2 Profiler PCR array. Total RNA
was isolated from the freshly purified c-kit1 cells by using RNeasy Mini Kit (Qiagen).
We took 1 mg of RNA from each sample and mixed to generate cDNA using RT2
First Strand Kit (SABiosciences). Mouse Molecular Toxicology Pathway Finder RT2
Profiler PCR array was done according to the manufacturer’s instructions
(SABiosciences), and a total of 370 genes representative of the 13 biological pathways
involved in response to toxicity was included in array (Supplementary Table 1). The
fold change of expression was calculated using web-based data analysis program
(SABiosciences).
Statistical analyses. All results are presented as the means 6 SD. The statistical
significance was determined by 1-way analysis of variance followed by post hoc test
(Dr. SPSS II, Chicago, IL). Differences were considered significant when p , 0.05.
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